A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on sterility.” ...

The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.

Sunscreen is not one size fits all, and Maryland dermatologist Dr. Kate Viola has recommendations that fit all age groups ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...

In a landmark victory for children's health and science-based medicine, the Court upheld a Tennessee law protecting minors ...

Doctors at Nemours Children's Hospital in Delaware are treating scoliosis in kids with something called "magic rods." ...

The FDA said Apotex didn’t issue a press release on May 28 when it made the actual recalls of the following products. Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, 105,456 bottles from ...

The FDA said Apotex didn’t issue a press release on May 28 when it made the actual recalls of the following products. Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, 105,456 bottles from ...

Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, 105,456 bottles from batch No. VD1654, expiration 06/30/2027.